Skip to main content
Erschienen in: Digestive Diseases and Sciences 2/2018

06.01.2018 | Editorial

Small Intestinal Bacterial Overgrowth and Coronary Artery Disease: What Is in the CArDs?

verfasst von: Christopher Adkins, Ali Rezaie

Erschienen in: Digestive Diseases and Sciences | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Excerpt

Small intestinal bacterial overgrowth (SIBO) manifests with a variety of gastrointestinal symptoms, including bloating, flatulence, abdominal pain, nausea, dyspepsia, fatigue, diarrhea, and constipation [1]. SIBO has been implicated as a cause of hepatic encephalopathy and of d-lactic acidosis in patients with short bowel syndrome [2, 3]. Moreover, SIBO is associated with a variety of conditions outside of the gastrointestinal system, including rosacea [4], restless legs syndrome [5], interstitial cystitis [6], and chronic prostatitis [7], and correlates with the level of somatic pain in fibromyalgia [8]. Along these lines, recent studies have reported a link between SIBO and cardiovascular disease. …
Literatur
1.
Zurück zum Zitat Rezaie A, Pimentel M, Rao SS. How to test and treat small intestinal bacterial overgrowth: an evidence-based approach. Curr Gastroenterol Rep. 2016;18:8.CrossRefPubMed Rezaie A, Pimentel M, Rao SS. How to test and treat small intestinal bacterial overgrowth: an evidence-based approach. Curr Gastroenterol Rep. 2016;18:8.CrossRefPubMed
2.
Zurück zum Zitat Rai R, Saraswat VA, Dhiman RK. Gut microbiota: its role in hepatic encephalopathy. J Clin Exp Hepatol. 2015;5:S29–S36.CrossRefPubMed Rai R, Saraswat VA, Dhiman RK. Gut microbiota: its role in hepatic encephalopathy. J Clin Exp Hepatol. 2015;5:S29–S36.CrossRefPubMed
3.
Zurück zum Zitat Bongaerts GP, Tolboom JJ, Naber AH, et al. Role of bacteria in the pathogenesis of short bowel syndrome-associated d-lactic acidemia. Microb Pathog. 1997;22:285–293.CrossRefPubMed Bongaerts GP, Tolboom JJ, Naber AH, et al. Role of bacteria in the pathogenesis of short bowel syndrome-associated d-lactic acidemia. Microb Pathog. 1997;22:285–293.CrossRefPubMed
5.
Zurück zum Zitat Weinstock LB, Walters AS. Restless legs syndrome is associated with irritable bowel syndrome and small intestinal bacterial overgrowth. Sleep Med. 2011;12:610–613.CrossRefPubMed Weinstock LB, Walters AS. Restless legs syndrome is associated with irritable bowel syndrome and small intestinal bacterial overgrowth. Sleep Med. 2011;12:610–613.CrossRefPubMed
6.
Zurück zum Zitat Weinstock LB, Klutke CG, Lin HC. Small intestinal bacterial overgrowth in patients with interstitial cystitis and gastrointestinal symptoms. Dig Dis Sci. 2008;53:1246–1251.CrossRefPubMed Weinstock LB, Klutke CG, Lin HC. Small intestinal bacterial overgrowth in patients with interstitial cystitis and gastrointestinal symptoms. Dig Dis Sci. 2008;53:1246–1251.CrossRefPubMed
7.
Zurück zum Zitat Weinstock LB, Geng B, Brandes SB. Chronic prostatitis and small intestinal bacterial overgrowth: effect of rifaximin. Can J Urol. 2011;18:5826–5830.PubMed Weinstock LB, Geng B, Brandes SB. Chronic prostatitis and small intestinal bacterial overgrowth: effect of rifaximin. Can J Urol. 2011;18:5826–5830.PubMed
8.
Zurück zum Zitat Pimentel M, Wallace D, Hallegua D, et al. A link between irritable bowel syndrome and fibromyalgia may be related to findings on lactulose breath testing. Ann Rheum Dis. 2004;63:450–452.CrossRefPubMedPubMedCentral Pimentel M, Wallace D, Hallegua D, et al. A link between irritable bowel syndrome and fibromyalgia may be related to findings on lactulose breath testing. Ann Rheum Dis. 2004;63:450–452.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Ponziani FR, Pompili M, Di Stasio E, Zocco MA, Gasbarrini A, Flore R. Subclinical atherosclerosis is linked to small intestinal bacterial overgrowth via vitamin K2-dependent mechanisms. World J Gastroenterol. 2017;23:1241–1249.CrossRefPubMedPubMedCentral Ponziani FR, Pompili M, Di Stasio E, Zocco MA, Gasbarrini A, Flore R. Subclinical atherosclerosis is linked to small intestinal bacterial overgrowth via vitamin K2-dependent mechanisms. World J Gastroenterol. 2017;23:1241–1249.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Giuliano V, Bassotti G, Mourvaki E, et al. Small intestinal bacterial overgrowth and warfarin dose requirement variability. Thromb Res. 2010;126:12–17.CrossRefPubMed Giuliano V, Bassotti G, Mourvaki E, et al. Small intestinal bacterial overgrowth and warfarin dose requirement variability. Thromb Res. 2010;126:12–17.CrossRefPubMed
12.
Zurück zum Zitat Rezaie A, Buresi M, Lembo A, et al. Hydrogen and methane-based breath testing in gastrointestinal disorders: the North American consensus. Am J Gastroenterol. 2017;112:775–784.CrossRefPubMedPubMedCentral Rezaie A, Buresi M, Lembo A, et al. Hydrogen and methane-based breath testing in gastrointestinal disorders: the North American consensus. Am J Gastroenterol. 2017;112:775–784.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Chang BW, Pimentel M, Chang C, et al. Prevalence of excessive intestinal methane production and its variability with age and gender: a large-scale database analysis. Gastroenterology. 2015;148:S729–S730. Chang BW, Pimentel M, Chang C, et al. Prevalence of excessive intestinal methane production and its variability with age and gender: a large-scale database analysis. Gastroenterology. 2015;148:S729–S730.
Metadaten
Titel
Small Intestinal Bacterial Overgrowth and Coronary Artery Disease: What Is in the CArDs?
verfasst von
Christopher Adkins
Ali Rezaie
Publikationsdatum
06.01.2018
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 2/2018
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-017-4904-4

Weitere Artikel der Ausgabe 2/2018

Digestive Diseases and Sciences 2/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.